Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/158000
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVitos Faleato, Jessica-
dc.contributor.authorReal, Sebastian-
dc.contributor.authorGutierrez Prat, Núria-
dc.contributor.authorVillanueva Garatachea, Alberto-
dc.contributor.authorLlonch, Elisabet-
dc.contributor.authorDrosten, Matthias-
dc.contributor.authorBarbacid, Mariano-
dc.contributor.authorNebreda, Àngel R.-
dc.date.accessioned2020-04-29T08:07:57Z-
dc.date.available2020-07-22T05:10:29Z-
dc.date.issued2020-01-22-
dc.identifier.urihttp://hdl.handle.net/2445/158000-
dc.description.abstractMalignant transformation entails important changes in the control of cell proliferation through the rewiring of selected signaling pathways. Cancer cells then become very dependent on the proper function of those pathways, and their inhibition offers therapeutic opportunities. Here we identify the stress kinase p38α as a nononcogenic signaling molecule that enables the progression of KrasG12V-driven lung cancer. We demonstrate in vivo that, despite acting as a tumor suppressor in healthy alveolar progenitor cells, p38α contributes to the proliferation and malignization of lung cancer epithelial cells. We show that high expression levels of p38α correlate with poor survival in lung adenocarcinoma patients, and that genetic or chemical inhibition of p38α halts tumor growth in lung cancer mouse models. Moreover, we reveal a lung cancer epithelial cell-autonomous function for p38α promoting the expression of TIMP-1, which in turn stimulates cell proliferation in an autocrine manner. Altogether, our results suggest that epithelial p38α promotes KrasG12V-driven lung cancer progression via maintenance of cellular self-growth stimulatory signals.ca
dc.format.extent8 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoengca
dc.publisherNational Academy of Sciencesca
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1073/pnas.1921404117-
dc.relation.ispartofPNAS, 2020, vol. 117, num. 5, p. 2588-2596-
dc.relation.urihttps://doi.org/10.1073/pnas.1921404117-
dc.rights(c) Vitos Faleato et al., 2020-
dc.sourceArticles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))-
dc.subject.classificationCèl·lules epitelialscat
dc.subject.classificationCàncer de pulmócat
dc.subject.otherEpithelial cellseng
dc.subject.otherLung cancereng
dc.titleRequirement for epithelial p38α in KRAS-driven lung tumor progressionca
dc.typeinfo:eu-repo/semantics/articleca
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid31969449-
Appears in Collections:Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
Vitos-Faleato_2020_Proc Natl Acad Sci USA.pdf9.09 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.